My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Moderna, Inc. - Common Stock (NQ:MRNA)

49.70 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Moderna, Inc. - Common Stock

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

June 26, 2024

Via Benzinga

Dow Nearly 100 Points Lower Amid Slumping Home Sales ↗

June 26, 2024

Via Talk Markets

Topics Stocks

Why Is Moderna Stock Trading Lower On Wednesday? ↗

June 26, 2024

The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in...

Via Benzinga

Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots ↗

June 26, 2024

After 18 months, Moderna's RSV vaccine proved about 50% effective against lower respiratory tract disease.

Via Investor's Business Daily

Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight ↗

June 26, 2024

On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threatens to undermine confidence the research abilities of the Darmstadt,...

Via Benzinga

Moderna's Options: A Look at What the Big Money is Thinking ↗

June 24, 2024

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $900 Today ↗

June 21, 2024

Via Benzinga

Market Whales and Their Recent Bets on MRNA Options ↗

June 20, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 25, 2024

Via Benzinga

What's Going On With Eli Lilly Stock On Tuesday? ↗

June 25, 2024

Eli Lilly collaborates with Microsoft-backed OpenAI to leverage generative AI for developing novel antimicrobials targeting drug-resistant pathogens. This partnership supports Lilly's commitment to...

Via Benzinga

Topics Artificial Intelligence

S&P 500, Nasdaq Lurking Below Record Highs ↗

June 18, 2024

Stocks are scattered this afternoon, as investors digest a weaker-than-expected retail sales reading from May.

Via Talk Markets

Topics Stocks

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment ↗

June 18, 2024

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...

Via Benzinga

Smart Money Is Betting Big In MRNA Options ↗

June 11, 2024

Via Benzinga

The RBA Kept Interest Rates On Hold And Remained Hawkish ↗

June 18, 2024

The Reserve Bank of Australia kept the cash rate at 4.35% at its June meeting, leaving borrowing costs unchanged for the fifth time.

Via Talk Markets

OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report ↗

June 17, 2024

OpenAI and startup Color Health have developed an AI assistant, named 'copilot', to support physicians in creating personalized cancer care plans, emphasizing the tool's role in augmenting rather than...

Via Benzinga

Topics Artificial Intelligence

Moderna Just Gave Investors Another Reason to Buy the Stock ↗

June 16, 2024

The company's post-pandemic prospects are getting brighter.

Via The Motley Fool

7 Struggling Stocks to Sell Before July 2024 ↗

June 12, 2024

The stock market is riding high for now. But even a roaring bull market can't save these seven stocks to sell.

Via InvestorPlace

3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants ↗

June 11, 2024

After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio.

Via InvestorPlace

What's Going On With Moderna Stock Monday? ↗

June 10, 2024

Moderna said its Phase 3 trial of mRNA-1083, an investigational combination vaccine against influenza and COVID-19, met its primary endpoints.

Via Benzinga

Nike, Merck, General Motors, And More: CNBC's 'Final Trades' ↗

June 10, 2024

Liz Young of SoFi recommends Energy Select Sector SPDR Fund as her final trade on CNBC's Halftime Report. Jim Lebenthal of Cerity Partners picks General Motors, while Jason Snipe of Odyssey Capital...

Via Benzinga

Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK ↗

June 10, 2024

If approved, this would be the first combination vaccine based on mRNA technology to hit the market.

Via Investor's Business Daily

Why Moderna Stock Is a No-Brainer Buy Right Now ↗

June 10, 2024

This messenger-RNA pioneer should be able to keep its rebound going.

Via The Motley Fool

3 Reasons to Buy Moderna Stock ↗

June 08, 2024

The biotech hasn't said its last word.

Via The Motley Fool

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season ↗

June 07, 2024

Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.

Via Benzinga

5 Stocks Propelling S&P 500 To 25th Record High ↗

June 06, 2024

While most of the stocks have performed well, here are five of them that led the way higher in yesterday's trading session.

Via Talk Markets

Topics Stocks

First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map ↗

June 06, 2024

Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.

Via Benzinga

FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program ↗

June 06, 2024

Moderna's mRNA-370 has been selected for the FDA's START program to accelerate rare disease therapeutics, targeting a 2024 pivotal study.

Via Benzinga

Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock? ↗

June 06, 2024

Novavax will be ready for the new Covid-19 JN.1 variants in September, but NVAX stock is also undergoing a short squeeze.

Via InvestorPlace

Novavax, With A 369% Gain, Tears Ahead Again On Key FDA Move ↗

June 06, 2024

Novavax also said it's planning to launch a JN.1-focused Covid booster shot this fall.

Via Investor's Business Daily

Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential ↗

June 05, 2024

If you have the patience and the ability to take a little risk, consider these three biotech stocks to buy since they can really pay off.

Via InvestorPlace

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.